Latest Breaking News On - Director carl - Page 16 : comparemela.com

Toll Brothers (NYSE:TOL) Given Neutral Rating at Wedbush

Toll Brothers (NYSE:TOL – Get Free Report)‘s stock had its “neutral” rating restated by equities research analysts at Wedbush in a research report issued to clients and investors on Friday, MarketBeat Ratings reports. They presently have a $73.00 price objective on the construction company’s stock. Wedbush’s price objective would indicate a potential downside of 4.43% […]

Douglasc jrCarlb marbachToll brothers company profileHarbour investments incToll brothers incOutfitter financialRoyal bankCredit suisse groupCapital advisorsGet free reportMarketbeat ratingsSuisse groupSeaport res ptnDirector carlWealth managementTraditional home building

Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Increased by Wedbush

Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Increased by Wedbush
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausCarll gordonInstitutional investors weigh in on theseus pharmaceuticalsTheseus pharmaceuticalsNeedham companyHighvista strategiesTheseus pharmaceuticals trading downTheseus pharmaceuticals incCantor fitzgeraldNews ratings for theseus pharmaceuticals dailyPrincipal financial group incDriehaus capital managementTheseus pharmaceuticals company profileFrazier life sciences managementSecurities exchange commissionFree report

Adicet Bio (NASDAQ:ACET) PT Lowered to $26 00 at HC Wainwright

Adicet Bio (NASDAQ:ACET) PT Lowered to $26 00 at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesCarll gordonAdicet bioJpmorgan chase coSchonfeld strategic advisorsSecurities exchange commissionTower research capitalSigma securitiesVirtu financialAdicet bio incFree reportDirector carlExchange commissionResearch capitalEmployees retirement systemStrategic advisors

Short Interest in Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Declines By 21 9%

Short Interest in Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Declines By 21 9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesCarll gordonStifel nicolausJpmorgan chase coAmerican international group incCantor fitzgeraldBarclays plcSecurities exchange commissionTheseus pharmaceuticals stock performanceNews ratings for theseus pharmaceuticals dailyCitigroup incNeedham companyTower research capitalTheseus pharmaceuticalsTheseus pharmaceuticals incGet free report

Adicet Bio s (ACET) Outperform Rating Reiterated at Wedbush

Wedbush reissued their outperform rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report released on Thursday, Benzinga reports. The firm currently has a $17.00 target price on the stock. A number of other analysts have also weighed in on the company. JPMorgan Chase & Co. lowered Adicet Bio from an overweight […]

Carll gordonAdicet bioJump financialSecurities exchange commissionAlpine global managementJpmorgan chase coAdicet bio incCarlyle group incAdicet bio company profileFree reportBio stock downDirector carlExchange commissionGlobal managementCarlyle groupGet free report